The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software cover art

The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

The Digital Health Podcast with Fexingo: Wearables, Diagnostics, and Health Software

By: Fexingo
Listen for free

Lucas and Luna explore the rapidly evolving world of digital health, where wearables track vitals, diagnostics shift to at-home testing, and software platforms reshape patient care. Each episode focuses on a specific development: how continuous glucose monitors are changing diabetes management, the FDA's latest clearance for an AI-driven ECG algorithm, or the business models behind telehealth startups like Ro and Hims & Hers. Lucas brings a journalist's precision to the numbers — market sizes, clinical trial results, reimbursement rates — while Luna challenges him on the real-world impact for clinicians and patients. They dissect earnings reports from Apple and Fitbit, parse policy moves from the FDA and CMS, and debate whether VC-funded digital health unicorns can sustain their valuations. Listeners — healthcare professionals, investors, tech strategists — get a clear-eyed briefing on what works, what's hype, and what's next in a sector where staying informed means understanding both the science and the business. How do you separate signal from noise when every startup claims to democratize healthcare? #DigitalHealth #Wearables #HealthTech #Telemedicine #FDA #RemotePatientMonitoring #HealthData #ClinicalTrials #StartupFunding #AppleWatch #Fitbit #ContinuousGlucoseMonitor #AIinHealthcare #VirtualCare #HealthcarePolicy #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo© 2026 Fexingo. All rights reserved. Economics
Episodes
  • How AI Is Unlocking Drug Discovery from Existing Molecules

    How AI Is Unlocking Drug Discovery from Existing Molecules
    Jun 29 2026
    Lucas and Luna explore how pharmaceutical companies and startups are using artificial intelligence to find new therapeutic uses for drugs already approved for other conditions. They focus on a specific case: a 2025 study where an AI model screened 4,000 existing compounds and identified a common blood pressure medication as a potential treatment for a rare genetic liver disease — cutting the typical discovery timeline from years to months. The hosts discuss the economics of repurposing versus developing new drugs, the data infrastructure needed, and why this approach could reshape how we think about pharmaceutical R&D. No hype — just the real mechanics of computational drug repurposing and what it means for patients and investors. #DrugDiscovery #AIinHealthcare #PharmaceuticalR&D #DrugRepurposing #MachineLearning #ComputationalBiology #RareDisease #ClinicalTrials #HealthTech #Biotech #PharmaInnovation #PrecisionMedicine #DataScience #GenerativeAI #LifeSciences #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
    Show More Show Less
    12 mins
  • How MedTech Is Using Breath Analysis for Early Disease Detection

    How MedTech Is Using Breath Analysis for Early Disease Detection
    Jun 28 2026
    Lucas and Luna explore the emerging field of breath-based diagnostics, focusing on how companies like Owlstone Medical are developing portable 'breathalyzers' that detect volatile organic compounds linked to lung cancer, asthma, and even infectious diseases. They discuss how this non-invasive technology could transform screening in primary care, the regulatory hurdles it faces, and the specific biomarkers being validated in clinical trials as of mid-2026. A concrete look at a technology that promises cheaper, faster, and more comfortable diagnosis. #BreathAnalysis #MedTech #Diagnostics #OwlstoneMedical #VolatileOrganicCompounds #LungCancerScreening #NonInvasiveDiagnosis #DigitalHealth #HealthTech #Biomarkers #PrimaryCare #ClinicalTrials #RegulatoryHurdles #FDA #PointOfCare #EarlyDetection #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
    Show More Show Less
    14 mins
  • How AI Is Transforming Mental Health Diagnosis from Speech

    How AI Is Transforming Mental Health Diagnosis from Speech
    Jun 28 2026
    In this episode, Lucas and Luna explore how artificial intelligence is analyzing speech patterns to detect mental health conditions like depression, anxiety, and PTSD. They discuss a landmark study from the University of Vermont that achieved 85% accuracy in identifying depression from voice recordings alone. The conversation covers how AI models can detect subtle acoustic biomarkers—pitch, tempo, breathiness—that clinicians might miss, the startups building commercial tools like Sonde Health and Kintsugi, and the ethical concerns around privacy and consent. Tune in to understand how your voice could become a vital sign for mental wellness. #MentalHealth #VoiceAI #DigitalHealth #AI #DepressionDetection #SpeechAnalysis #SondeHealth #Kintsugi #UniversityOfVermont #AcousticBiomarkers #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech #AIinHealthcare #MentalWellness #Startup Keep every episode free: buymeacoffee.com/fexingo
    Show More Show Less
    9 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet